R3i Foundation (@r3i_foundation) 's Twitter Profile
R3i Foundation

@r3i_foundation

🔬 The Residual Risk Reduction Initiative (R3i) is a non-profit foundation recognizing the complications in patients with atherogenic dyslipidemia.

ID: 4918728173

linkhttp://www.r3i.org calendar_today16-02-2016 09:51:08

1,1K Tweet

5,5K Followers

214 Following

R3i Foundation (@r3i_foundation) 's Twitter Profile Photo

Prof. Anne Tybjaerg-Hansen discusses the Mendelian randomization, a type of natural randomized trial that has been used to expand the evidence supporting elevated TG as causal for cardiovascular risk. ➡️ youtube.com/watch?v=wLPUwb… Visit r3i.org for more info. #R3i

R3i Foundation (@r3i_foundation) 's Twitter Profile Photo

Accreditation by AACI confirms R3i is a trusted authority in the field of Residual Vascular Risk. Become a member to receive our newsletter and get unrestricted access to downloadable slidekits. ➡️ r3i.org #R3i #ResidualRisk #ResidualRiskReduction

Accreditation by AACI confirms R3i is a trusted authority in the field of Residual Vascular Risk.

Become a member to receive our newsletter and get unrestricted access to downloadable slidekits. ➡️ r3i.org

#R3i #ResidualRisk #ResidualRiskReduction
R3i Foundation (@r3i_foundation) 's Twitter Profile Photo

Having a stroke puts people at a higher risk for a second one, however, stroke survivors have the power to reduce their risk for having another stroke. There are things they can do to reduce their risk, starting with identifying what caused their stroke and uncovering all of

Having a stroke puts people at a higher risk for a second one, however, stroke survivors have the power to reduce their risk for having another stroke.

There are things they can do to reduce their risk, starting with identifying what caused their stroke and uncovering all of
R3i Foundation (@r3i_foundation) 's Twitter Profile Photo

このたびR3i Foundationでは、「代謝機能障害関連脂肪性肝炎(MASH)」に関する最新の教育コンテンツを公開いたしました。現在、当財団ウェブサイトよりご覧いただけます。

このたびR3i Foundationでは、「代謝機能障害関連脂肪性肝炎(MASH)」に関する最新の教育コンテンツを公開いたしました。現在、当財団ウェブサイトよりご覧いただけます。
R3i Foundation (@r3i_foundation) 's Twitter Profile Photo

Dr. Ruth McPherson discusses if triglycerides are related to cardiovascular risk. ➡️ youtu.be/PyBpN_ZM1Ws Visit r3i.org for more info. #R3i #ResidualRisk #ResidualRiskReduction #MedicalResearch #Triglycerides #Cardiovascular #CardioTwitter #CardiovascularRisk

R3i Foundation (@r3i_foundation) 's Twitter Profile Photo

There is a wealth of evidence from observational studies over the decades linking elevated plasma triglycerides (TG), a surrogate for TG-rich lipoproteins and their remnants, with increased cardiovascular risk. More recently, genetic studies added support for a likely causative

There is a wealth of evidence from observational studies over the decades linking elevated plasma triglycerides (TG), a surrogate for TG-rich lipoproteins and their remnants, with increased cardiovascular risk.

More recently, genetic studies added support for a likely causative
R3i Foundation (@r3i_foundation) 's Twitter Profile Photo

Atherosclerotic Cardiovascular Disease (ASCVD) is the hardening and narrowing of the arteries caused by cholesterol plaques lining the artery walls over time. This can restrict blood flow as the arteries become blocked. This condition can be also referred to as arteriosclerosis

Atherosclerotic Cardiovascular Disease (ASCVD) is the hardening and narrowing of the arteries caused by cholesterol plaques lining the artery walls over time. This can restrict blood flow as the arteries become blocked.

This condition can be also referred to as arteriosclerosis
R3i Foundation (@r3i_foundation) 's Twitter Profile Photo

Atherosclerotic Cardiovascular Disease (ASCVD) is the hardening and narrowing of the arteries caused by cholesterol plaques lining the artery walls over time. This can restrict blood flow as the arteries become blocked. This condition can be also referred to as arteriosclerosis

Atherosclerotic Cardiovascular Disease (ASCVD) is the hardening and narrowing of the arteries caused by cholesterol plaques lining the artery walls over time. This can restrict blood flow as the arteries become blocked.

This condition can be also referred to as arteriosclerosis
R3i Foundation (@r3i_foundation) 's Twitter Profile Photo

Founded by Professor Jean-Charles Fruchart in 2008, The Residual Risk Reduction Initiative (R3i) Foundation is a pioneering organization dedicated to addressing residual vascular risk through strategic initiatives. The R3i is a global, academic, multidisciplinary, non-profit

Founded by Professor Jean-Charles Fruchart in 2008, The Residual Risk Reduction Initiative (R3i) Foundation is a pioneering organization dedicated to addressing residual vascular risk through strategic initiatives.

The R3i is a global, academic, multidisciplinary, non-profit
R3i Foundation (@r3i_foundation) 's Twitter Profile Photo

Dr. Ruth McPherson explains how genetics has helped to identify new targets for managing triglycerides. ➡️ youtu.be/wRYFnfew7UY Visit r3i.org for more info. #R3i #ResidualRisk #ResidualRiskReduction #MedicalResearch #Triglycerides

R3i Foundation (@r3i_foundation) 's Twitter Profile Photo

Arteries are blood vessels that carry blood from the heart throughout the body. They're lined by a thin layer of cells called the endothelium. It keeps the inside of the arteries in shape and smooth, which keeps blood flowing. Atherosclerosis begins with damage to the

Arteries are blood vessels that carry blood from the heart throughout the body. They're lined by a thin layer of cells called the endothelium. It keeps the inside of the arteries in shape and smooth, which keeps blood flowing.

Atherosclerosis begins with damage to the
R3i Foundation (@r3i_foundation) 's Twitter Profile Photo

Latest data from the Global Burden of Disease Study 2021 highlight a global epidemic of obesity in children and adolescents. Forecasting data indicate that about one-third of children and adolescents will be overweight or obese by 2050. As obesity is one of the foremost

Latest data from the Global Burden of Disease Study 2021 highlight a global epidemic of obesity in children and adolescents.

Forecasting data indicate that about one-third of children and adolescents will be overweight or obese by 2050.

As obesity is one of the foremost
R3i Foundation (@r3i_foundation) 's Twitter Profile Photo

The stages of atherosclerosis happen over many years and include: 1) Damage to the endothelium. When the layer of cells that lines the artery walls is damaged, this starts a process that leads to inflammation there. 2) Fatty streak. This yellow streak results when the white

The stages of atherosclerosis happen over many years and include:

1) Damage to the endothelium. When the layer of cells that lines the artery walls is damaged, this starts a process that leads to inflammation there.

2) Fatty streak. This yellow streak results when the white
R3i Foundation (@r3i_foundation) 's Twitter Profile Photo

June is a month dedicated to raising awareness about Alzheimer's disease and promoting brain health. Alzheimer's and Brain Awareness Month serves as an opportunity to educate ourselves, support those affected by the disease, and take proactive steps to maintain optimal brain

June is a month dedicated to raising awareness about Alzheimer's disease and promoting brain health.

Alzheimer's and Brain Awareness Month serves as an opportunity to educate ourselves, support those affected by the disease, and take proactive steps to maintain optimal brain
R3i Foundation (@r3i_foundation) 's Twitter Profile Photo

Dr. Ruth McPherson explains what treatments are available for managing triglycerides and what the issues are.➡️ youtu.be/Xj4-JCF8hzc Visit r3i.org for more info. #R3i #ResidualRisk #MedicalResearch #Triglycerides #Cardiovascular #ResidualCardiovascularRisk

R3i Foundation (@r3i_foundation) 's Twitter Profile Photo

Alzheimer’s disease (AD) is the most common cause of dementia. It is a neurodegenerative disease that affects the brain, meaning it damages and destroys brain cells over time. Eventually, people with AD lose some brain functions, including memory and language. Alzheimer’s

Alzheimer’s disease (AD) is the most common cause of dementia. It is a neurodegenerative disease that affects the brain, meaning it damages and destroys brain cells over time. Eventually, people with AD lose some brain functions, including memory and language.

Alzheimer’s
R3i Foundation (@r3i_foundation) 's Twitter Profile Photo

An elevated remnant cholesterol level was independently associated with increased risks of all-cause dementia, Alzheimer’s disease, and vascular dementia, according to this nationwide, population-based cohort study in South Korea. Dyslipidemia has consistently demonstrated a

An elevated remnant cholesterol level was independently associated with increased risks of all-cause dementia, Alzheimer’s disease, and vascular dementia, according to this nationwide, population-based cohort study in South Korea.

Dyslipidemia has consistently demonstrated a
R3i Foundation (@r3i_foundation) 's Twitter Profile Photo

Dr. Ruth McPherson explains how we can improve on current treatments for high triglycerides. ➡️ youtu.be/TpIBdFw6Vls Visit r3i.org for more info. #R3i

R3i Foundation (@r3i_foundation) 's Twitter Profile Photo

As the size of the U.S. population age 65 and older continues to grow, so too will the number and proportion of Americans with Alzheimer's or other dementias. By 2030, all members of the baby boom generation (Americans born between 1946 and 1964) will be age 65 or older, the age

As the size of the U.S. population age 65 and older continues to grow, so too will the number and proportion of Americans with Alzheimer's or other dementias.

By 2030, all members of the baby boom generation (Americans born between 1946 and 1964) will be age 65 or older, the age
R3i Foundation (@r3i_foundation) 's Twitter Profile Photo

Metabolic dysfunction-associated fatty liver disease (MAFLD), formerly known as NAFLD, includes a range of liver conditions from simple steatosis to its severe form, MASH (metabolic dysfunction-associated steatohepatitis). Its global prevalence has increased by over 50% in the

Metabolic dysfunction-associated fatty liver disease (MAFLD), formerly known as NAFLD, includes a range of liver conditions from simple steatosis to its severe form, MASH (metabolic dysfunction-associated steatohepatitis).

Its global prevalence has increased by over 50% in the